Gerald E. Commissiong
Founder presso AMARANTUS BIOSCIENCE HOLDINGS, INC.
Profilo
Mr. Gerald E.
Commissiong is a President, Chief Executive Officer & Director at Todos Medical Ltd., an Executive Chairman & President at Amarantus Bioscience Holdings, Inc., a Chief Executive Officer at Breakthrough Diagnostics, Inc., a Chief Executive Officer at Cutanogen Corp., a President at Provista Diagnostics, Inc. and a President, Secretary, Treasurer & Director at Elto Pharma, Inc. He is on the Board of Directors at Todos Medical Ltd.
and Elto Pharma, Inc. Mr. Commissiong was previously employed as a Chief Operating Officer & Director by Jumpkicks, Inc. He also served on the board at Theralink Technologies, Inc. (Colorado).
He received his undergraduate degree from Stanford University.
Posizioni attive di Gerald E. Commissiong
| Società | Posizione | Inizio |
|---|---|---|
| AMARANTUS BIOSCIENCE HOLDINGS, INC. | Founder | 14/01/2008 |
| TODOS MEDICAL LTD. | Chief Executive Officer | 05/01/2020 |
Cutanogen Corp.
 Cutanogen Corp. BiotechnologyHealth Technology Part of Gemini Strategies LLC, Inc., Cutanogen Corp. is a private company that develops artificial skin products used to treat patients with severe burns. The company is based in Cincinnati, OH. The CEO of the company is Gerald E. Commissiong. Cutanogen was acquired by Amarantus Bioscience Holdings, Inc. from Lonza Group AG on July 15, 2015 for $9 million. | Chief Executive Officer | - |
Elto Pharma, Inc.
 Elto Pharma, Inc. Pharmaceuticals: MajorHealth Technology Elto Pharma, Inc. develops Eltoprazine, an oral small molecule 5HT1A/1B partial agonist in clinical development for the treatment of Parkinson's disease levodopa-induced dyskinesia (PD-LID), aggression in Alzheimer's disease and adult attention deficit hyperactivity disorder (adult ADHD).The company was founded on April 12, 2017 and is headquartered in Nevada, the United States of America. | President | - |
Breakthrough Diagnostics, Inc.
 Breakthrough Diagnostics, Inc. BiotechnologyHealth Technology Breakthrough Diagnostics, Inc. engages in the development of blood tests for the early detection of neurodegenerative disorders. Its primary product is the Lympro Test, a blood screening diagnostic test for Alzheimer’s disease. The company is headquartered in New York, NY. | Chief Executive Officer | - |
Provista Diagnostics, Inc.
 Provista Diagnostics, Inc. Miscellaneous Commercial ServicesCommercial Services Provista Diagnostics, Inc. operates as a diagnostic company. It focuses on the development and commercialization of proprietary blood based diagnostic, prognostic, and monitoring tests in women's cancer. Its products include videssa breast, ovarian, endometrial, and HPV associated. The company is headquartered in Alpharetta, GA. | President | - |
Precedenti posizioni note di Gerald E. Commissiong
| Società | Posizione | Fine |
|---|---|---|
Jumpkicks, Inc.
 Jumpkicks, Inc. Specialty StoresRetail Trade Jumpkicks, Inc. provides online retailing services. The company also provides content of interest to martial artists and selling products, such as uniforms, t-shirts, protective equipment, mats and other equipment and accessories. The company was founded on August 3, 2007 and is headquartered in Henderson, NV. | Chief Operating Officer | 08/06/2011 |
| AVANT DIAGNOSTICS INC | Director/Board Member | - |
Formazione di Gerald E. Commissiong
| Stanford University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| AMARANTUS BIOSCIENCE HOLDINGS, INC. | Health Technology |
| TODOS MEDICAL LTD. | Health Technology |
| Aziende private | 6 |
|---|---|
Jumpkicks, Inc.
Jumpkicks, Inc. Specialty StoresRetail Trade Jumpkicks, Inc. provides online retailing services. The company also provides content of interest to martial artists and selling products, such as uniforms, t-shirts, protective equipment, mats and other equipment and accessories. The company was founded on August 3, 2007 and is headquartered in Henderson, NV. | Retail Trade |
Cutanogen Corp.
Cutanogen Corp. BiotechnologyHealth Technology Part of Gemini Strategies LLC, Inc., Cutanogen Corp. is a private company that develops artificial skin products used to treat patients with severe burns. The company is based in Cincinnati, OH. The CEO of the company is Gerald E. Commissiong. Cutanogen was acquired by Amarantus Bioscience Holdings, Inc. from Lonza Group AG on July 15, 2015 for $9 million. | Health Technology |
Provista Diagnostics, Inc.
Provista Diagnostics, Inc. Miscellaneous Commercial ServicesCommercial Services Provista Diagnostics, Inc. operates as a diagnostic company. It focuses on the development and commercialization of proprietary blood based diagnostic, prognostic, and monitoring tests in women's cancer. Its products include videssa breast, ovarian, endometrial, and HPV associated. The company is headquartered in Alpharetta, GA. | Commercial Services |
Elto Pharma, Inc.
Elto Pharma, Inc. Pharmaceuticals: MajorHealth Technology Elto Pharma, Inc. develops Eltoprazine, an oral small molecule 5HT1A/1B partial agonist in clinical development for the treatment of Parkinson's disease levodopa-induced dyskinesia (PD-LID), aggression in Alzheimer's disease and adult attention deficit hyperactivity disorder (adult ADHD).The company was founded on April 12, 2017 and is headquartered in Nevada, the United States of America. | Health Technology |
Breakthrough Diagnostics, Inc.
Breakthrough Diagnostics, Inc. BiotechnologyHealth Technology Breakthrough Diagnostics, Inc. engages in the development of blood tests for the early detection of neurodegenerative disorders. Its primary product is the Lympro Test, a blood screening diagnostic test for Alzheimer’s disease. The company is headquartered in New York, NY. | Health Technology |
Theralink Technologies, Inc. (Colorado)
 Theralink Technologies, Inc. (Colorado) Medical SpecialtiesHealth Technology Theralink Technologies, Inc. engages in the provision of biomarker assay services in the areas of oncology. The firm offers personalized medicine data through TheraLink assays to assist the biopharmaceutical industry and clinical oncologists in identifying drug treatments. It develops phosphoproteomic technologies that measure the activation status of signaling pathways. The company was founded on October 16, 2008 and is headquartered in Golden, CO. | Health Technology |
- Borsa valori
- Insiders
- Gerald E. Commissiong
